The world’s pharmaceutical industry continued its trend of consolidation Thursday as Sweden-based drug company Meda announced plans to acquire Italy’s Rottapharm for $3.1 billion.
Reports say the takeover marks the largest merger ever struck in Media’s history.
The pharmaceutical giant had earlier said that it prefers “to eat and not be eaten” …read more
Source: Global Competition Law Blogs